Your browser doesn't support javascript.
loading
Effectiveness of Adjuvant Pembrolizumab vs High-Dose Interferon or Ipilimumab for Quality-of-Life Outcomes in Patients With Resected Melanoma: A Secondary Analysis of the SWOG S1404 Randomized Clinical Trial.
Unger, Joseph M; Darke, Amy; Othus, Megan; Truong, Thach-Giao; Khushalani, Nikhil; Kendra, Kari; Lewis, Karl D; Faller, Bryan; Funchain, Pauline; Buchbinder, Elizabeth I; Tarhini, Ahmad A; Kirkwood, John M; Sharon, Elad; Sondak, Vernon; Guild, Samantha R; Grossmann, Kenneth; Ribas, Antoni; Patel, Sapna P.
Afiliación
  • Unger JM; SWOG Statistics and Data Management Center, Fred Hutchinson Cancer Center, Seattle, Washington.
  • Darke A; SWOG Statistics and Data Management Center, Fred Hutchinson Cancer Center, Seattle, Washington.
  • Othus M; SWOG Statistics and Data Management Center, Fred Hutchinson Cancer Center, Seattle, Washington.
  • Truong TG; Kaiser Perm Northern California, Vallejo, California.
  • Khushalani N; H. Moffitt Cancer Center and Research Institute, Tampa, Florida.
  • Kendra K; Ohio State University, Columbus.
  • Lewis KD; University of Colorado Cancer Center, Aurora.
  • Faller B; Heartland NCORP/Missouri Baptist Medical Center, St Louis.
  • Funchain P; Cleveland Clinic, Cleveland, Ohio.
  • Buchbinder EI; Dana Farber Cancer Institute, Boston, Massachusetts.
  • Tarhini AA; H. Moffitt Cancer Center and Research Institute, Tampa, Florida.
  • Kirkwood JM; The University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
  • Sharon E; National Cancer Institute, Bethesda, Maryland.
  • Sondak V; H. Moffitt Cancer Center and Research Institute, Tampa, Florida.
  • Guild SR; AIM at Melanoma, San Rafael, California.
  • Grossmann K; Merck and Co, Kenilworth, New Jersey.
  • Ribas A; UCLA Jonsson Comprehensive Cancer Center, Los Angeles, California.
  • Patel SP; The University of Texas MD Anderson Cancer Center, Houston.
JAMA Oncol ; 9(2): 251-260, 2023 02 01.
Article en En | MEDLINE | ID: mdl-36416836
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Calidad de Vida / Melanoma Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Female / Humans / Male / Middle aged Idioma: En Revista: JAMA Oncol Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Calidad de Vida / Melanoma Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Female / Humans / Male / Middle aged Idioma: En Revista: JAMA Oncol Año: 2023 Tipo del documento: Article